1.
Nishizawa A, Satoh T, Yokozeki H. Erythrodermic Psoriasis Improved by Panitumumab, But Not Bevacizumab. Acta Derm Venereol [Internet]. 2012 Mar. 21 [cited 2024 Oct. 19];92(4):360-1. Available from: https://medicaljournalssweden.se/actadv/article/view/8880